YungShin Global Holding Corp
TWSE:3705
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
45.55
62.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
YungShin Global Holding Corp
Current Portion of Long-Term Debt
YungShin Global Holding Corp
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Current Portion of Long-Term Debt
NT$91.3m
|
CAGR 3-Years
40%
|
CAGR 5-Years
43%
|
CAGR 10-Years
20%
|
|
Formosa Laboratories Inc
TWSE:4746
|
Current Portion of Long-Term Debt
NT$480.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
||
ScinoPharm Taiwan Ltd
TWSE:1789
|
Current Portion of Long-Term Debt
NT$18.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
||
S
|
SCI Pharmtech Inc
TWSE:4119
|
Current Portion of Long-Term Debt
NT$129.1m
|
CAGR 3-Years
328%
|
CAGR 5-Years
134%
|
CAGR 10-Years
N/A
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Current Portion of Long-Term Debt
NT$1.4B
|
CAGR 3-Years
30%
|
CAGR 5-Years
39%
|
CAGR 10-Years
32%
|
||
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Current Portion of Long-Term Debt
NT$83.4m
|
CAGR 3-Years
64%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-2%
|
YungShin Global Holding Corp
Glance View
YungShin Global Holding Corp. engages in resources integration and business development. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-01-03. The firm mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The firm also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.
See Also
What is YungShin Global Holding Corp's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
91.3m
TWD
Based on the financial report for Jun 30, 2024, YungShin Global Holding Corp's Current Portion of Long-Term Debt amounts to 91.3m TWD.
What is YungShin Global Holding Corp's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
20%
Over the last year, the Current Portion of Long-Term Debt growth was 561%. The average annual Current Portion of Long-Term Debt growth rates for YungShin Global Holding Corp have been 40% over the past three years , 43% over the past five years , and 20% over the past ten years .